Mednax, Inc. (MD) News
Filter MD News Items
MD News Results
|Loading, please wait...|
MD News Highlights
- For MD, its 30 day story count is now at 24.
- Over the past 23 days, the trend for MD's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
- The most mentioned tickers in articles about MD are CFR, LOAN and PD.
Latest MD News From Around the Web
Below are the latest news stories about Mednax Inc that investors may wish to consider to help them evaluate MD as an investment opportunity.
FORT LAUDERDALE, Fla., February 24, 2022--Mednax and its Pediatrix-affiliated practices will host two premier meetings in neonatal medicine March 1-6 in San Diego.
FORT LAUDERDALE, Fla., February 23, 2022--Mednax to Present at 2022 J.P. Morgan Global High Yield and Leveraged Finance Conference
Mednax's (MD) Q4 results improve on better revenues and expanded patient volumes.
MEDNAX, Inc. (MD) Q4 2021 Earnings Conference Call February 17, 2022, 9:00 AM ET Company Participants Mark Ordan – Chief Executive Officer Marc Richards – Chief Financial Officer Jim Swift – Chief Development Officer Charles Lynch – Senior Vice President, Finance & Strategy Dr. Roger Mack Hinson – Head of...
The Carlyle Group (NASDAQ: CG) is bringing on two new independent board members while a longtime director retires — moves that will expand the company's board size and tip the scales so that a majority of members will be independent. Linda Hefner Filler and Mark Ordan will join the board of the D.C. private equity giant, effective April 1. Filler is the former president of retail products, chief marketing officer and chief merchandising officer at Walgreen Co. She retired from that position in 2017 and now serves on the boards for D.C.’s Danaher Corp. and Palo Alto, California’s Eversight Inc. Ordan is currently CEO at Mednax Inc. (NYSE: MD), a national medical group based in Sunrise, Florida.
View more earnings on MDSee more from BenzingaWest Pharmaceutical's Q4 Performance Surpass Expectations, Expects FY22 Sales To Increase 8%Established Brands Hit Organon's Q4 Sales, Expects FY22 Sales Of Upto .4B© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Mednax (MD) delivered earnings and revenue surprises of 18.18% and 3.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
FORT LAUDERDALE, Fla., February 17, 2022--Mednax to Present at SVB Leerink 11th Annual Global Healthcare Conference
FORT LAUDERDALE, Fla., February 17, 2022--Mednax Reports Fourth Quarter Results
Community Health Systems (CYH) delivered earnings and revenue surprises of 130% and 0.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?